Skip to main content

Electra Therapeutics, Inc.

corporate_fare Company Profile

Electra Therapeutics, Inc.

ETRA·NASDAQ·Life Sciences·CIK 0002088082

Electra Therapeutics is a clinical-stage biotechnology company that develops therapies targeting signal regulatory proteins for diseases in immunology and cancer. Its product, ELA026, is a monoclonal antibody designed to target signal regulatory protein on the cell surface of myeloid and T cells. ELA026 works by depleting pathological immune cells, which allows medical professionals to find an approved treatment for secondary hemophagocytic lymphohistiocytosis, a life-threatening hyperinflammatory condition. The company was incorporated in 2018 and operates from South San Francisco, California.

Electra Therapeutics, Inc. (NASDAQ:ETRA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 6 items for ETRA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 6 most recent items scored 7 or higher, the top rating is 8/10, with 3 rated 8 or above. Recent SEC coverage for ETRA spans 4, SCHEDULE 13D, 424B4.

Recent high-impact activity:

  • OrbiMed Buys $3.6M of Electra Therapeutics Open-Market Days After IPO
  • OrbiMed Discloses 11% Stake in Electra Therapeutics After IPO Conversion
  • ADARx Soars 30% in Debut After $446M Upsized IPO; AbbVie Takes 4.9% Stake
  • OrbiMed Buys $20M in Electra IPO, Converts $69M Preferred Stake
  • Electra Therapeutics Prices $350M IPO at $15/Share, Lists on Nasdaq as ETRA

Short Interest & Short Volume

1.70 days to cover

FINRA reported short interest of 484,020 shares in ETRA as of the October 30, 2026 settlement, a 18.2% increase from the prior period — about 1.7 days to cover at its recent average daily volume. On November 20, 2026, 59.1% of ETRA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)484,020 shares as of October 30, 2026
Change vs prior period▲ 18.2%
Days to cover1.70 at avg daily volume of 285,287
Daily short volume (FINRA facilities)59.1% of 162,900 shares on November 20, 2026
5-day average short volume55.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for ETRA, detected from its recent SEC filings · based on capital-structure filings through 2026-09-18.

1 recent capital raise

IPO Priced at $15.00 Per Share · Net Proceeds of $319.9 Million

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with E →
$8.11
52-week range · as of 2026-11-05 $6.87 – $15.5
Market cap
$509.85M
Volume
376.1K (1.0× avg)
3-mo avg 375.2K
Live data · 2026-11-22 12:40 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ETRA - Latest Insights

ETRA
Nov 05, 2026, 5:39 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $7.35
Real-time Price: $8.11 info
Change: +$0.760 (+10%) info
Market Cap: $509.85M info
ETRA
Sep 25, 2026, 5:11 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $11.43
Real-time Price: $8.11 info
Change: -$3.32 (-29%) info
Market Cap: $509.85M info
ETRA
Sep 25, 2026, 12:21 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $11.63
Real-time Price: $8.11 info
Change: -$3.52 (-30%) info
Market Cap: $509.85M info
ETRA
Sep 23, 2026, 5:29 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $12.50
Real-time Price: $8.11 info
Change: -$4.39 (-35%) info
Market Cap: $509.85M info
ETRA
Sep 18, 2026, 4:52 PM EDT
Filing Type: 424B4
Importance Score:
8
Price at Filing: $13.49
Real-time Price: $8.11 info
Change: -$5.38 (-40%) info
Market Cap: $509.85M info
ETRA
Sep 17, 2026, 8:37 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: N/A
Real-time Price: $8.11 info
Change: N/A info
Market Cap: $509.85M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets